Triphase Pharmaceuticals Private Limited, a active private limited company, was established on 01 June 2006 in Mysore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U73100KA2006PTC039605. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.65 M and a paid-up capital of ₹1.25 M.
It upholds a compliant status. Employing 12 professional, Its leadership includes Perumal Manoharan (Additional Director), Aditya Desiraju (Additional Director). Past directors included Desiraju Rajagopal Rao, Desiraju Srilakshmi, Chandrappa Seetharamaiah. Its latest AGM occurred on 30 July 2025, with the balance sheet filed on 31 March 2023. It is based at No 694 Double Road Saraswathipuram, Mysore, Karnataka, 570009.
U73100KA2006PTC039605
039605
01 June 2006
₹1.65 M
₹1.25 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Triphase Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Perumal Manoharan | Additional Director | 02 Mar 2023 | Current |
| Aditya Desiraju | Additional Director | 02 Mar 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 May 2017 | Past |
| Pramod Abcsdd | Director | 09 Apr 2016 | Past |
| Pramod Abcsdd | Director | 02 Mar 2023 | Past |
| Pramod Abcsdd | Director | 26 May 2017 | Past |
| Pramod Abcsdd | Director | 12 Jun 2019 | Past |
| Pramod Abcsdd | Director | 12 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Triphase Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 233.15% increase. The company also saw a substantial fall in profitability, with a 50.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 188.32%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Triphase Pharmaceuticals had a promoter holding of 99.64% and a public holding of 0.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Triphase Pharmaceuticals has a workforce of 12 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Triphase Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Triphase Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Triphase Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Jul 2025 as per latest MCA records. was completed.
Progress on Triphase Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was documented.
Perumal Manoharan was appointed as a Additional Director was appointed as a Additional Director on 02 Mar 2023 & has been associated with this company since 2 years 9 months . was recorded as a recent event.
Progress on Aditya Desiraju was appointed as a Additional Director was appointed as a Additional Director on 02 Mar 2023 & has been associated with this company since 2 years 9 months . was documented.
Progress on Triphase Pharmaceuticals Private Limited was registered on 01 Jun 2006 with Roc Bangalore & aged 19 years 6 months as per MCA records. was documented.
The CIN of Triphase Pharmaceuticals Private Limited is U73100KA2006PTC039605.
Triphase Pharmaceuticals Private Limited is headquartered at No 694 Double Road Saraswathipuram, Mysore, Karnataka, 570009.
Triphase Pharmaceuticals Private Limited was incorporated on 01 June 2006.
The current directors of Triphase Pharmaceuticals Private Limited are
The primary industry of Triphase Pharmaceuticals Private Limited is Manufacturing.
Triphase Pharmaceuticals Private Limited is unlisted.
The authorized capital of Triphase Pharmaceuticals Private Limited is ₹1.65 M, and the paid-up capital is ₹1.25 M.
The compliance status of Triphase Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX